The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "
Device Transactions During 2014’s third quarter, device firms raised a total of $734 million, less than half of Q2’s $1.6 billion. ( See Exhibit 1. ) The deal activity was pretty evenly spread out amo